Claro Advisors LLC Bristol Myers Squibb CO Transaction History

Claro Advisors LLC

$706 Million
Q3 2024

A detailed history of Claro Advisors LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Claro Advisors LLC holds 24,738 shares of BMY stock, worth $1.39 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

24,738

Previous 163 15076.69%

Holding current value

$1.39 Million

Previous $8,000 15900.0%

% of portfolio

0.18%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$39.66 - $51.75 $974,644 - $1.27 Million	24,575 Added 15076.69%	24,738 $1.28 Million
Q3 2024 Oct 17, 2024	SELL	$39.66 - $51.75 $913,964 - $1.19 Million	-23,045 Reduced 99.3%	163 $8,000
Q2 2024 Jul 31, 2024	BUY	$40.25 - $52.99 $57,517 - $75,722	1,429 Added 6.56%	23,208 $963,000
Q1 2024 Apr 18, 2024	BUY	$47.98 - $54.4 $140,245 - $159,011	2,923 Added 15.5%	21,779 $1.18 Million
Q4 2023 Jan 22, 2024	SELL	$48.48 - $57.85 $152,857 - $182,401	-3,153 Reduced 14.33%	18,856 $967,000
Q3 2023 Oct 10, 2023	BUY	$57.89 - $64.73 $51,348 - $57,415	887 Added 4.2%	22,009 $1.28 Million
Q2 2023 Aug 08, 2023	BUY	$63.71 - $70.74 $88,047 - $97,762	1,382 Added 7.0%	21,122 $1.35 Million
Q1 2023 Apr 17, 2023	BUY	$65.71 - $74.53 $97,842 - $110,975	1,489 Added 8.16%	19,740 $1.37 Million
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $210,644 - $249,432	3,076 Added 20.27%	18,251 $1.31 Million
Q2 2022 Aug 12, 2022	BUY	$72.62 - $79.98 $41,611 - $45,828	573 Added 3.92%	15,175 $1.17 Million
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $4,344 - $5,064	81 Added 0.56%	14,602 $910,000
Q3 2021 Nov 15, 2021	SELL	$59.17 - $69.31 $94,790 - $111,034	-1,602 Reduced 9.94%	14,521 $859,000
Q2 2021 Aug 13, 2021	BUY	$61.91 - $67.42 $6,500 - $7,079	105 Added 0.66%	16,123 $1.08 Million
Q1 2021 May 17, 2021	BUY	$59.34 - $66.74 $121,706 - $136,883	2,051 Added 14.68%	16,018 $1.01 Million
Q4 2020 Feb 12, 2021	SELL	$57.74 - $65.43 $5,427 - $6,150	-94 Reduced 0.67%	13,967 $866,000
Q3 2020 Nov 16, 2020	SELL	$57.43 - $63.64 $24,982 - $27,683	-435 Reduced 3.0%	14,061 $848,000
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $4,769 - $5,575	87 Added 0.6%	14,496 $852,000
Q1 2020 May 15, 2020	SELL	$46.4 - $67.43 $2,227 - $3,236	-48 Reduced 0.33%	14,409 $803,000
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $54,278 - $70,801	1,103 Added 8.26%	14,457 $928,000
Q3 2019 Oct 29, 2019	SELL	$42.77 - $50.71 $34,729 - $41,176	-812 Reduced 5.73%	13,354 $677,000
Q2 2019 Jul 24, 2019	BUY	$44.62 - $49.34 $3,792 - $4,193	85 Added 0.6%	14,166 $642,000
Q1 2019 May 10, 2019	SELL	$45.12 - $53.8 $29,598 - $35,292	-656 Reduced 4.45%	14,081 $672,000
Q4 2018 Feb 14, 2019	BUY	$48.76 - $63.23 $718,576 - $931,820	14,737 New	14,737 $915,000

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $120B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Claro Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Claro Advisors LLC with notifications on news.

Account

Claro Advisors LLC Bristol Myers Squibb CO Transaction History